Radiation dose reduction for CT-guided intrathecal nusinersen administration in adult patients with spinal muscular atrophy

被引:9
|
作者
Cordts, Isabell [1 ]
Deschauer, Marcus [1 ]
Lingor, Paul [1 ]
Burian, Egon [2 ]
Baum, Thomas [2 ]
Zimmer, Claus [2 ]
Maegerlein, Christian [2 ]
Sollmann, Nico [2 ,3 ]
机构
[1] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany
[2] Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Klinikum Rechts Isar, Munich, Germany
[3] Tech Univ Munich, TUM Neuroimaging Ctr, Klinikum Rechts Isar, Munich, Germany
关键词
LUMBAR PUNCTURE;
D O I
10.1038/s41598-020-60240-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intrathecal administration of nusinersen in adult spinal muscular atrophy (SMA) patients with scoliosis and spondylodesis requires image guidance, which is preferably achieved with multi-detector computed tomography (MDCT). As long-term treatment is necessary and patients are young, radiation doses should be reduced to a minimum whilst a sufficient image quality for precise interventional performance should be kept. We compared 44 MDCT standard-dose scans (133.0-200.0 mA) with a hybrid iterative reconstruction (iDose4) to 20 low-dose scans (20.0-67.0 mA) with iterative model reconstruction (IMR), which were performed for procedure planning of intrathecal nusinersen administration in 13 adult patients with SMA and complex spinal conditions. Qualitative image evaluation, including confidence for intervention planning, was performed by two neuroradiologists for standard- and low-dose scans. All 64 MDCT-guided intrathecal administrations of nusinersen were successful. The dose length product (DLP) was significantly lower when using low-dose scanning with IMR (median DLP of standard-dose scans: 92.0 mGy.cm vs. low-dose scans: 34.5 mGy.cm; p < 0.0001). Image quality was significantly reduced for low-dose compared to standard-dose scanning. However, bone/soft tissue contrast and confidence for intervention planning were not significantly impaired in low-dose MDCT according to both readers, showing good inter-reader agreement. Thus, we hereby demonstrate a low-dose MDCT protocol combined with advanced image reconstruction for scanning during procedure planning as a viable option for image guidance in intrathecal nusinersen treatment of adult SMA patients with complex spinal conditions.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Administration of nusinersen via paramedian approach for spinal muscular atrophy
    Iwayama, Hideyuki
    Wakao, Norimitsu
    Kurahashi, Hirokazu
    Kubota, Norika
    Hattori, Ayako
    Kumagai, Toshiyuki
    Okumura, Akihisa
    BRAIN & DEVELOPMENT, 2021, 43 (01): : 121 - 126
  • [42] Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen
    Bonanno, Silvia
    Zanin, Riccardo
    Bello, Luca
    Tramacere, Irene
    Bozzoni, Virginia
    Caumo, Luca
    Ferraro, Manfredi
    Bortolani, Sara
    Soraru, Gianni
    Silvestrini, Mauro
    Vacchiano, Veria
    Turri, Mara
    Tanel, Raffaella
    Liguori, Rocco
    Coccia, Michela
    Mantegazza, Renato Emilio
    Mongini, Tiziana
    Pegoraro, Elena
    Maggi, Lorenzo
    JOURNAL OF NEUROLOGY, 2022, 269 (06) : 3264 - 3275
  • [43] Nusinersen in adult patients with spinal muscular atrophy Observations from a single center
    Moshe-Lilie, Orly
    Visser, Amy
    Chahin, Nizar
    Ragole, Thomas
    Dimitrova, Diana
    Karam, Chafic
    NEUROLOGY, 2020, 95 (04) : E413 - E426
  • [44] Nusinersen by subcutaneous intrathecal catheter for symptomatic spinal muscular atrophy patients with complex spine anatomy
    Carson, Vincent J.
    Young, Millie
    Brigatti, Karlla W.
    Robinson, Donna L.
    Reed, Robert M.
    Sohn, Jihee
    Petrillo, Marco
    Farwell, Wildon
    Miller, Freeman
    Strauss, Kevin A.
    MUSCLE & NERVE, 2022, 65 (01) : 51 - 59
  • [45] Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult with 5q-Related Spinal Muscular Atrophy Type 1 and Severe Spinal Deformity
    Papaliagkas, Vasileios
    Foroglou, Nikolaos
    Toulios, Petros
    Moschou, Maria
    Gavriilaki, Maria
    Notas, Konstantinos
    Chatzikyriakou, Evangelia
    Zafeiridou, Georgia
    Arnaoutoglou, Marianthi
    Kimiskidis, Vasilios K.
    CASE REPORTS IN NEUROLOGY, 2021, 13 (03) : 710 - 715
  • [46] Fluoroscopic guidance for intrathecal delivery of nusinersen in pediatric patients with spinal muscular atrophy and complex spines
    Lando-Dotan, Shany
    Perlow, Eliyahu
    Zemer, Vered Shkalim
    Levine, Hagit
    Bruckheimer, Elchanan
    Tzeitlin, Yelena
    Steinberg, Tamar
    Nevo, Yoram
    Shochat, Tzipora
    Aharoni, Sharon
    NEUROMUSCULAR DISORDERS, 2025, 49
  • [47] Anesthetic management of pediatric patients undergoing intrathecal nusinersen administration for treatment of spinal muscular atrophy: A single-center experience
    Brollier, Lauren D.
    Matuszczak, Maria
    Marri, Tejaswi
    Carbajal, Jael G.
    Moorman, Andrew T.
    Sorial, Emad M.
    Jain, Ranu
    PEDIATRIC ANESTHESIA, 2021, 31 (02) : 160 - 166
  • [48] Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience
    Hache, Manon
    Swoboda, Kathryn J.
    Sethna, Navil
    Farrow-Gillespie, Alan
    Khandji, Alexander
    Xia, Shuting
    Bishop, Kathie M.
    JOURNAL OF CHILD NEUROLOGY, 2016, 31 (07) : 899 - 906
  • [49] A RETROSPECTIVE COHORT STUDY OF CHILDREN WITH SPINAL MUSCULAR ATROPHY TYPE 2 RECEIVING ANESTHESIA FOR INTRATHECAL ADMINISTRATION OF NUSINERSEN
    Bielsky, Alan R.
    Yaster, Myron
    Fuhr, Peter G.
    Parsons, Julie A.
    ANESTHESIA AND ANALGESIA, 2018, 126 (04): : 501 - 501
  • [50] A retrospective cohort study of children with spinal muscular atrophy type 2 receiving anesthesia for intrathecal administration of nusinersen
    Bielsky, Alan R.
    Fuhr, Peter G.
    Parsons, Julie A.
    Yaster, Myron
    PEDIATRIC ANESTHESIA, 2018, 28 (12) : 1105 - 1108